Zeitschrift für Phytotherapie 2022; 42(05): 216-220
DOI: 10.1055/a-1874-9617

Phytotherapeutika zur Behandlung von vasomotorischen Symptomen im Klimakterium

Susan Zeun

Vasomotorische Symptome treten in der Peri- und Postmenopause auf und sind eines der Hauptsymptome der Wechseljahre, weshalb Frauen Hilfe suchen. Es gibt zahlreiche phytotherapeutische Möglichkeiten, diese Beschwerden zu behandeln. In Abhängigkeit von Begleitsymptomen (Unruhe, Schlaflosigkeit, depressive Verstimmungen) und dem zeitlichen Auftreten bzgl. des reproduktiven Zyklus der Betroffenen ist eine individuelle Behandlung möglich.

Publication History

Article published online:
24 October 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Literatur

  • 1 Avis NE, Crawford SL. et al. Psychosocial, behavioral, and health factors related to menopause symptomatology. Womens Health 1997; 3: 103-120
  • 2 Avis NE, Crawford SL, Greendale G. et al. Study of Women’s Health Across the Nation. Duration of Menopausal Vasomotor Symptoms Over the Menopause Transition. JAMA Intern Med 2015; 175: 531-539
  • 3 Deecher DC. Physiology of thermoregulatory dysfunction and current approaches to the treatment of vasomotor symptoms. Expert Opin Investig Drugs 2005; 14: 434-448
  • 4 Szegila A, Czyzyz A. et al. The role of kisspeptin/neurokinin B/dynorphin neurons in pathomechanism of vasomotor symptoms in postmenopausal women: from physiology to potential therapeutic applications. Gynecol Endocrinol 2018; 34: 913-919
  • 5 Dietz BM. et al. Botanicals and their bioactive phytochemicals for women’s health. Pharmacol Rev 2016; 68: 1026-1073
  • 6 AWMF. S3-Leitlinienprogramm: Peri- und Postmenopause – Diagnostik und Interventionen. Im Internet: https://www.awmf.org/uploads/tx_szleitlinien/015-062l_S3_HT_Peri-Postmenopause-Diagnostik-Interventionen_2021-01.pdf Abruf 06.09.2022
  • 7 Schilcher H. Hrsg. Leitfaden Phytotherapie. 5. Aufl. München: Elsevier/Urban & Fischer; 2016: 63-64
  • 8 Bent S, Padula A. et al. Valerian for sleep: a systematic review and meta-analysis. Am J Med 2006; 119: 1005-1101
  • 9 Semwal P, Painuli S. et al. Diosgenin: An updated pharmacological review and therapeutic perspective. Oxid Med Cell Longev 2022; 2022: 1035441
  • 10 Greco S, Pellegrino P. et al. Phytoprogestins: unexplored food compounds with potential preventive and therapeutic effects in female diseases. Nutrients 2021; 13: 4326
  • 11 Swaroop A, Jaipuriar AS, Gupta SK. et al. Efficacy of a novel fenugreek seed extract (Trigonella foenum-graecum, Furocyst) in polycystic ovary syndrome (PCOS). Int J Med Sci 2015; 12: 825-831
  • 12 Schilcher H. Hrsg. Leitfaden Phytotherapie. 5. Aufl. München: Elsevier/Urban & Fischer; 2016: 160-161
  • 13 Milligan SR, Kalita JC. et al. Identification of a potent phytoestrogen in hops (Humulus lupulus L.) and beer. J Clin Endocrinol Metab 1999; 84: 2249-2252
  • 14 Aghamiri V, Mirghafourvand M. et al. The effect of hop (Humulus lupulus L.) on early menopausal symptoms and hot flashes: A randomized placebo-controlled trial. Complement Ther Clin Pract 2016; 23: 130-135
  • 15 Kenda M, Glavac N. et al. Herbal products used in menopause and for gynecological disorders. Molecules 2021; 26: 7421
  • 16 Nanashima N, Horie K. et al. Phytoestrogenic activity of blackcurrant anthocyanins is partially mediated through estrogen receptor beta. Molecules 2017; 23: 74
  • 17 Neary JT, Bu Y. Hypericum LI 160 inhibits uptake of serotonin and norepinephrine in astrocytes. Brain Res 1999; 816: 358-363
  • 18 Eatemadnia A, Ansari S. et al. The effect of Hypericum perforatum on postmenopausal symptoms and depression: A randomized controlled trial. Complement Ther Med 2019; 45: 109-113
  • 19 Dew TP, Williamson G. Controlled flax interventions for the improvement of menopausal symptoms and postmenopausal bone health: a systematic review. Menopause 2013; 20: 1207-1215
  • 20 Colli M, Bracht A. et al. Evaluation of the efficacy of flaxseed meal and flaxseed extract in reducing menopausal symptoms. J Med Food 2012; 15: 840-845
  • 21 Hoberg E, Orjala J. et al. Diterpenoids from the fruits of Vitex agnus-castus . Phytochemistry 1999; 52: 1555-1558 DOI: 10.1016/S0031-9422(99)00181-8.
  • 22 Marjoribanks J, Brown J. et al. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev 2013; CD001396 DOI: 10.1002/14651858.CD001396.pub3.
  • 23 Van Die MD, Burger HG. et al. Vitex agnus-castus (Chaste-tree/berry) in the treatment of menopause-related complaints. J Altern Complement Med 2009; 15: 853-862
  • 24 Wober J, Möller F. et al. Activation of estrogen receptor-beta by a special extract of Rheum rhaponticum (ERr 731), its aglycones and structurally related compounds. J Steroid Biochem Mol Biol 2007; 107: 191-201
  • 25 Thomas AJ, Ismail R. et al. Effects of isoflavones and amino acid therapies for hot flashes and co-occurring symptoms during the menopausal transition and early postmenopause: a systematic review. Maturitas 2014; 78: 263-276
  • 26 Mohsen A, Fatemeh K. et al. Pharmacological and therapeutic properties of the red clover (Trifolium pratense L.): an overview of the new findings. J Tradit Chin Med 2021; 41: 642-649
  • 27 Rahte S, Evans R. et al. Salvia officinalis for hot flushes: towards determination of mechanism of activity and active principles. Planta Med 2013; 79: 753-760 DOI: 10.1055/s-0032-1328552.
  • 28 European Medicines Agency. . European Union herbal monograph on Salvia officinalis L., folium. Im Internet: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-salvia-officinalis-l-folium-revision-1_en.pdf; Abruf 06.09.2022
  • 29 Smith T, Gillespie M, Eckl V. et al. Herbal supplement sales in US increase by 9.4% in 2018. Herbalgram 2019; 123: 62-73
  • 30 Jarry H, Gorkow C, Wuttke W. Treatment of Menopausal Symptoms with Extracts of Cimicifuga racemosa: In vivo and in vitro Evidence for Estrogenic Activity. In: Loew D, Rietbrock N, Hrsg. Phytopharmaka in Forschung und klinischer Anwendung. Berlin, Heidelberg: Springer; 1995: 99-112 DOI: 10.1007/978-3-642-85434-7_8
  • 31 Kennelly E, Baggett S, Nuntanakorn P. et al. Analysis of thirteen populations of black cohosh for formononetin. Phytomedicine 2002; 9: 461-467
  • 32 Wuttke W, Gorkow C, Seidlová-Wuttke D. Effects of black cohosh (Cimicifuga racemosa) on bone turnover, vaginal mucosa, and various blood parameters in postmenopausal women. Menopause 2006; 13: 185-196
  • 33 Mohapatra S, Iqubal A. et al. Benefits of black cohosh (Cimicifuga racemosa) for women health: An up-close and in-depth review. Pharmaceuticals (Basel) 2022; 15: 278